MicroPythonOS lightweight OS for microcontroller targets applications with graphical user interfaces with a look similar to Android/iOS.

Google plans to replace ChromeOS with a new platform called Aluminium OS, combining the best of its existing computing ...

Multi-OS devices are finally becoming viable as Google, Microsoft, and Lenovo rethink how operating systems coexist across modern hardware.

Nothing OS 4.0 update rolling out to CMF Phone 1 in India, Phone 2 Pro next Update brings visual changes, enhanced dark mode, and new widget size options Rollout is phased by region and device batch ...

FDA confirmed that data from single-arm studies in rare diseases, such as in ultra-rare deadly pediatric cancer osteosarcoma, could support a Biologics Licensing Application (BLA) under Accelerated ...

Microsoft rolls out Model Context Protocol support in Windows ML, providing tools to build agentic Windows applications that work with local and remote resources securely. One concern many users have ...

Nothing’s latest software upgrade is reaching more users, with the Android 16-based Nothing OS 4.0 now rolling out to the Phone 3a and Phone 3a Pro, according to a GSMArena report. The update, which ...

Google is assessing a new direction for its software strategy as it examines how Android could be adapted for desktop-class hardware. Although Android has expanded widely across phones, tablets, TVs, ...

Google is preparing to find new ways in its software strategy as it explores how Android could work on traditional computers. The company has spent years expanding Android beyond smartphones, watches ...

The big picture: Google is reportedly developing a new Android-based operating system for traditional PCs. Codenamed "Aluminium," the OS is expected to replace ChromeOS, Google's cloud-focused laptop ...

Nothing will begin rolling out its Android 16-based Nothing OS 4.0 update on 21 November after an extended beta phase. The release brings new AI features, interface upgrades and wider device support, ...

Type C Meeting with US FDA set for December 11, 2025 to address key items following August 27, 2025 End of Phase 2 Meeting regarding Phase 2b clinical trial of OST-HER2: prevention or delay of ...